Retatrutide is a next-generation triple agonist peptide that simultaneously activates GLP-1, GIP, and glucagon receptors for superior weight loss and metabolic results. This advanced compound delivers exceptional fat reduction, improved glycemic control, and increased energy expenditure, positioning it as one of the most powerful research peptides for obesity and metabolic health.
Research Use Only
This product is intended for laboratory research purposes only. Not for human consumption or clinical use.